| Literature DB >> 35198396 |
Jiefeng Xiao1, Shukai Zheng1, Zhaolong Qiu1, Kusheng Wu1.
Abstract
OBJECTIVE: Interleukin-1 (IL-1) is a pro-inflammatory cytokine which may be related to urolithiasis. Genetic polymorphisms of the interleukin-1beta (IL-1β) have been proposed as markers for urolithiasis in some areas. Due to the high incidence of urolithiasis in Uighur children (Xinjiang, China) and existence of ethnic difference, our aim is to explore the potential of IL-1 gene polymorphisms and urolithiasis among these children.Entities:
Keywords: IL-1RN variable number of tandem repeat gene; IL-1β (+3954) gene; IL-1β (−511) gene; Single nucleotide polymorphisms; Uighur children; Urolithiasis
Year: 2021 PMID: 35198396 PMCID: PMC8841271 DOI: 10.1016/j.ajur.2021.04.009
Source DB: PubMed Journal: Asian J Urol ISSN: 2214-3882
Figure 1The results of agarose gel electrophoresis. (A) IL-1RN VNTR gene; (B) IL-1β (−511) gene; (C) IL-1β (+3954) gene. I/I, IL-1RN VNTR gene wild type; II/IV, I/III, I/IV and I/II, IL-1RN VNTR gene heterozygote; II/II, IL-1RN VNTR gene mutant type; T/C, IL-1β (−511) gene heterozygote; C/C, IL-1β (−511) gene wild type; T/T, IL-1β (−511) gene mutant type; E1/E2, IL-1β (+3954) gene heterozygote; E1/E1, IL-1β (+3954) gene wild type; E2/E2, IL-1β (+3954) gene mutant type; IL-1β, interleukin-1beta; VNTR, variable number of tandem repeat.
Genotype distribution of IL-1RN VNTR gene, IL-1β (−511) gene, and IL-1β (+3954) gene polymorphism between patients and controls.
| Gene | Genotype | Patient, | Control, | OR (95% CI) | |
|---|---|---|---|---|---|
| I/I | 71 (61.7) | 59 (60.2) | 0.605 | 1.00 | |
| I/II | 36 (31.3) | 27 (27.6) | 0.90 (0.49–1.66) | ||
| II/II | 5 (4.4) | 7 (7.1) | 1.69 (0.51–5.59) | ||
| Others | 3 (2.6) | 5 (5.1) | 2.01 (0.46–8.74) | ||
| C/C | 31 (27.0) | 25 (25.5) | 0.949 | 1.00 | |
| T/C | 55 (47.8) | 49 (50.0) | 1.11 (0.58–2.12) | ||
| T/T | 29 (25.2) | 24 (24.5) | 0.97 (0.46–2.07) | ||
| E1/E1 | 71 (61.7) | 69 (70.4) | 0.169 | 1.00 | |
| E1/E2 | 41 (35.7) | 24 (24.5) | 0.60 (0.33–1.10) | ||
| E2/E2 | 3 (2.6) | 5 (5.1) | 0.58 (0.13–2.53) |
IL-1RN VNTR, interleukin-1 receptor antagonist variable number of tandem repeat; IL-1β, interleukin-1beta; OR, odds ratio; CI, confidence interval; I, IL-1RN VNTR gene wild type; II, IL-1RN VNTR gene mutant type; III and IV, IL-1RN VNTR gene heterozygote; C, IL-1β (−511) gene wild type; T, IL-1β (−511) gene mutant type; E1, IL-1β (+3954) gene wild type; E2, IL-1β (+3954) gene mutant type.
Allele frequencies of IL-1RN VNTR gene, IL-1β (−511) gene, and IL-1β (+3954) gene in patients and controls.
| Gene | Allele | Patient, | Control, | OR (95% CI) | |
|---|---|---|---|---|---|
| I | 180 (78.3) | 149 (76.4) | 0.799 | 1.00 | |
| II | 47 (20.4) | 41 (21.0) | 1.05 (0.66–1.69) | ||
| III | 2 (0.9) | 4 (2.1) | 2.42 (0.44–13.38) | ||
| IV | 1 (0.4) | 1 (0.5) | 1.21 (0.08–19.48) | ||
| C | 117 (50.9) | 99 (50.5) | 0.941 | 1.00 | |
| T | 113 (49.1) | 97 (49.5) | 0.99 (0.67–1.44) | ||
| E1 | 183 (79.6) | 162 (82.7) | 0.418 | 1.00 | |
| E2 | 47 (20.4) | 34 (17.3) | 1.22 (0.75–2.00) |
IL-1RN VNTR, interleukin-1 receptor antagonist variable number of tandem repeat; IL-1β, interleukin-1beta; OR, odds ratio; CI, confidence interval; I, IL-1RN VNTR gene wild type; II, IL-1RN VNTR gene mutant type; III and IV, IL-1RN VNTR gene heterozygote; C, IL-1β (−511) gene wild type; T, IL-1β (−511) gene mutant type; E1, IL-1β (+3954) gene wild type; E2, IL-1β (+3954) gene mutant type.
Carriage rate of IL-1RN VNTR gene, IL-1β (−511) gene and IL-1β (+3954) gene in patients and controls.
| Gene | Carriage | Patient, | Control, | OR (95% CI) | |
|---|---|---|---|---|---|
| I | 109 (70.8) | 91 (70.0) | 0.810 | – | |
| II | 42 (27.3) | 34 (26.2) | |||
| III | 2 (1.3) | 4 (3.1) | |||
| IV | 1 (0.6) | 1 (0.7) | |||
| C | 86 (50.3) | 74 (50.3) | 0.965 | 1.00 | |
| T | 85 (49.7) | 73 (49.7) | |||
| E1 | 112 (71.8) | 93 (76.2) | 0.404 | 1.00 | |
| E2 | 44 (28.2) | 29 (23.8) |
IL-1RN VNTR, interleukin-1 receptor antagonist variable number of tandem repeat; IL-1β, interleukin-1beta; OR, odds ratio; CI, confidence interval. I, IL-1RN VNTR gene wild type. II, IL-1RN VNTR gene mutant type. III and IV, IL-1RN VNTR gene heterozygote. C, IL-1β (−511) gene wild type. T, IL-1β (−511) gene mutant type. E1, IL-1β (+3954) gene wild type. E2, IL-1β (+3954) gene mutant type. –, not available.